← Back to headlines
Evercore ISI Adjusts Outlook for Viridian Therapeutics
Evercore ISI has revised its outlook for Viridian Therapeutics, Inc. (VRDN) in a pre-earnings preview. The adjustment reflects the firm's updated analysis ahead of the company's upcoming earnings report.
17 Apr, 13:37 — 17 Apr, 13:37
Sources
Showing 1 of 1 sources
